Overview


According to FutureWise analysis the market for auto injectors in 2023 is US$ 1.89 billion, and is expected to reach US$ 7.97 billion by 2031 at a CAGR of 19.70%.

Auto-injectors are medical devices that are designed to deliver a pre-measured dose of medication into the body through a needle. They are commonly used for a variety of conditions, including severe allergic reactions, multiple sclerosis, rheumatoid arthritis, and certain types of cancer. Auto-injectors are typically small, portable, and easy to use, making them a convenient option for patients who need to self-administer their medication regularly.

One of the main benefits of auto-injectors is that they allow patients to administer medication quickly and easily without the need for medical personnel. This can be especially important in emergencies, such as when a patient is experiencing a severe allergic reaction or an asthma attack. With an auto-injector, patients can quickly deliver the medication they need to manage their symptoms and potentially save their lives. Another benefit of auto-injectors is that they can help improve patient adherence to medication regimens. Many chronic conditions require ongoing treatment with medication, and patients may need to self-administer their medication on a regular basis. Auto-injectors make this process more convenient and less intimidating, which can help improve patient adherence and outcomes. In addition to their convenience and ease of use, auto-injectors are also designed to deliver medication in a precise and controlled manner. This can help ensure that patients receive the correct dose of medication every time, which is especially important for conditions that require careful dosing.

FutureWise Market Research has published a report that provides an insightful analysis of Auto Injectors Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Auto Injectors Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Abbvie
  • Mylan
  • ELI Lilly
  • Ypsomed
  • Amgen
  • Becton Dickinson and Co.
  • Owen Mumford
  • Consort Medical
  • Haselmeir
  • Shl Group
  • Johnson And Johnson
  • Teva
  • Antares Pharma
  • Sanofi
  • Pfizer, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Auto Injectors Market:

  • In May 2022, The Qfinity autoinjector system was introduced by Jabil Healthcare, a branch of Jabil Inc., and is more affordable than competing products on the market. It is a straightforward, reusable, modular solution for self-administration of subcutaneous (SC) medication.

The auto-injectors market has been experiencing steady growth in recent years, driven by several factors. One of the main drivers of the market is the increasing prevalence of chronic diseases, which require ongoing treatment with medication. Many of these medications can be self-administered with auto-injectors, which provide patients with a convenient and efficient way to manage their conditions. Another factor contributing to the growth of the auto-injectors market is the increasing focus on patient-centered care and self-management. Patients are getting increasingly engaged in their own healthcare and are seeking out treatments that offer greater convenience and control. Auto-injectors are an ideal solution for patients who need to self-administer medication, as they allow patients to take their medication on their own terms and in the comfort of their homes. In addition to these patient-driven factors, the auto-injectors market is also benefiting from technological advances and product design. Auto-injectors are becoming more user-friendly and easier to use, with features such as automatic needle retraction and audible cues to help guide patients through the injection process. These innovations are making auto-injectors more accessible to a wider range of patients and helping to drive the market's growth.

One of the key challenges facing the auto-injectors market is the cost of these devices. While auto-injectors offer many benefits, they can be more expensive than other drug delivery methods, such as traditional syringes and needles. This can be a barrier to adoption for some patients and healthcare providers and may limit the market's growth in certain regions.

By Therapy

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies

By Type

  • Disposable Auto Injectors
  • Reusable Auto Injectors
    • Prefilled Auto Injectors
    • Empty Auto Injectors

By End User

  • Home Care Settings
  • Hospitals And Clinics
  • Ambulatory Care Settings

By Route of Administration

  • Subcutaneous
  • Intramuscular

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Asia-pacific region is estimated to grow at the highest CAGR throughout the forecast period. Throughout the projected timeframe, Asia-pacific is anticipated to account for a sizable portion of the worldwide market for auto-injectors. The market in this region is boosted by factors such as early acceptance of technologically advanced items and product approvals, as well as an increase in the incidence of chronic disorders. A high prevalence of chronic disorders like cancer drives the market in this region. In addition, the auto-injectors market is growing due to the rising technical improvements, the increased entrance of new competitors, and the quick acceptance of innovative goods, especially in India and China. The Asia-pacific region is therefore anticipated to expand throughout the projected period as a result of the aforementioned variables.

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global Auto Injectors Market By Therapy, By Type, By End User, By Route Of Administration and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Auto Injectors Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances

  • 5.   Auto Injectors Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Auto Injectors Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Auto Injectors Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Auto Injectors Market, By Therapy Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Rheumatoid Arthritis
        2. Multiple Sclerosis
        3. Diabetes
        4. Anaphylaxis
        5. Other Therapies

  • 8.   Auto Injectors Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Disposable Auto Injectors
        2. Reusable Auto Injectors
         2.1. Prefilled Auto Injectors
         2.2. Empty Auto Injectors

  • 9.   Auto Injectors Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Home Care Settings
        2. Hospitals And Clinics
        3. Ambulatory Care Settings

  • 10.   Auto Injectors Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Subcutaneous
        2. Intramuscular

  • 11.   North America Auto Injectors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Auto Injectors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Auto Injectors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Auto Injectors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)

    •   1. Abbvie
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Mylan
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. ELI Lilly
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Ypsomed
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Amgen
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Becton Dickinson and Co.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Owen Mumford
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Consort Medical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Haselmeir
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Shl Group
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Johnson And Johnson
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Teva
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Antares Pharma
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Sanofi
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Pfizer, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11